Clinical research is a healthcare branch that studies the health & ill health of people. It examines the efficacy and side-effects of medicines, devices, treatments, and other medical products used for human cures. The Clinical Research Division of VMRC is a renowned center of clinical research in India. We use deep research and analysis to explore better ways of disease prevention, diagnosis, and treatment. Our clinical trial center is a space for a series of valid investigations designed to check if the new drugs and treatments are safe & effective. Thus, clinical research and clinical trials are crucial steps in a medicine's development cycle before it can be finally delivered for usage in clinics, hospitals, and other healthcare centers.
The CRD at Venus Remedies Limited enabling
novel and systemized research aimed at driving the healthcare system in
a positive and meaningful direction. With dedicated facilities and
teams to support clinical trial and research, CRD is capable of
supporting clinicians and organizations alike in the development of
new healthcare drug delivery systems.
The services of the department cover the entire study cycle; from feasibility studies to archival and even more assistance provided to marketing authorization of new drugs. In line with high ethical standards, the CRD also ensures that clinical studies are conducted in compliance with regulatory requirements that ensure and protect the safety, wellbeing, and rights of the study subjects.
CRD comprises of a dynamic, vibrant and
dedicated team of medical and pharmacy professionals with diverse
skill sets and unique talents. We have procedures in place to fully
inform participants of potential benefits and risks, to protect the
confidentiality of their private information, and to protect
vulnerable populations. CRD at Venus abides by the guidelines for
good clinical practice of the international conference for
We firmly believe in people engagement and
ensure growth and fulfillment to our associates through our skill
enhancement programs like CME programs for clinicians, nurses and
allied healthcare professionals. There is a wealth of clinical
knowledge to be gained from the experience of our senior doctors
and other stakeholders.
We believe in equal opportunities & fairness and provide growth opportunities to associates by offering stretch assignments and the opportunity to work in cross-functional teams. Individual & team contributions are rewarded & recognized through various awards at group and unit levels.
We invite you to explore the vast possibilities at CRD and discover a rewarding life of innovation, teamwork, and achievement.
research is crucial to excellence in clinical care and seems
self-evident, the reason research and patient care need to exist
side by side.
and foremost, to add more advances in clinical research which
offers the benefit of immediate therapies for our patients.
the ability to offer clinical trials/PMS studies to patients who
have diseases for which effective therapies are not available which
gives both patients and their doctors a sense of hope and optimism
for the future.
and most importantly, a research environment that is truly
excellent attracts the best doctors, because they feel their
talents will be appreciated and they want to contribute.
A good working environment that demands excellence in clinical research ensures excellence in patient care. The two are not separable. The CRD was established to ensure excellence in research at all the phases by providing the resources our scientists need to thrive. Included in this are the development of core competency, site selection, key opinion leader’s identification and the opportunity to develop collaborations across disciplines.
Antibiotic Resistance an unmet
medical need of the hour
rise of antibiotic resistance is leading to clinicians being
increasingly faced with clinical failure due to the lack of
effective and safe treatment options. New antibiotics clinical
trials are needed now for current multi-drug resistant infections
but also in preparation for emerging and anticipated threats. Hence
to give more emphasis on an antibiotic clinical study.
generate a valuable idea or piece of research and overcome the
challenges for good medical writing work within the CRD
International PMS studies
PMS studies would be encouraged to add more demographic safety data
to our existing approved drug products.
Herbal Clinical Trial
products have become an important and indispensable part of public
healthcare around the world. Various surveys on traditional and
alternative medicine have highlighted their widespread use. A
report of a global survey on national policy on traditional
medicine and regulation of herbal medicines indicated that about 50
countries including China, Japan, and Germany already have their
national policy and laws on regulations of traditional medicines.
Hence give more emphasis on a clinical trial on Integrated natural
medicine to provide a natural solution for various diseases.
Clinical Research & Division
Dr. Mohd Amin
Director | Clinical Research
Team Leader | Clinical Research
CRA | Clinical Research
Contact at: email@example.com
Recently Published Work
Management of Pneumonia and Blood Stream Infections with New Antibiotic Adjuvant Entity (Ceftriaxone + Sulbactam + Disodium Edetate).
A Novel Way to Spare Carbapenems; J Clin Diagn Res. 2016 Dec; 10(12): LC23–LC27:
Mohammad Shameem and Mohammad Amin Mir
Carbapenems Sparing Antibiotics in the Management of Urinary Tract Infections Caused by Multi-Drug Resistant Gram-Negative Organisms.
A New Way to Control Growing Incidences of Carbapenem-Resistant Enterobacteriaceae:
J Basic Clin Pharma 2017;8: 34-38: Samad A, Harris H, Mir MA
Safety and efficacy of a novel drug ELORES (ceftriaxone+sulbactam+disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers.
a post-marketing surveillance study; Braz J Infect Dis. 2017 Jul - Aug;21(4):408-417:
Chaudhary M, Mir MA, Ayub SG; Protocol 06 Group.
Post-Marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-Use Analysis in Paediatric Patients with Hospital.
Acquired Pneumonia: Journal of Clinical and Diagnostic Research; September 2018/Volume:12/Issue:9/Page:25-28:
Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir
Comparative efficacy and safety analysis of CSE-1034: An open-labeled phase III study in community-acquired pneumonia;
Journal of Infection and Public Health. 2018 May 24. pii: S1876-0341(18)30042-X. doi: 10.1016/j.jiph.2018.04.006.
Chaudhary M, Ayub SG, Mir MA; protocol 05 group.